Johnson & Johnson sues to stop Medicare negotiation
Pharmaceutical giant Johnson & Johnson is the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.
Related Articles
Accreditation agencies take on telehealth with new virtual care standards
The Joint Commission and the National Committee for Quality Assurance will launch updated accreditation programs for telehealth providers.
Use evidence to support early coverage of gene therapy after accelerated approval
Gene therapies represent an evidence problem. Because they are just beginning to be used, little long-term data exists on their effectiveness and downstream risks.
In a scientific first, researchers use CRISPR base editing to treat liver disease in fetal monkeys
In a scientific first, researchers have used CRISPR base editing to treat liver disease in fetal monkeys.
Biden administration finalizes abortion privacy protections
HHS released a final rule that would put abortion services under the same federal privacy protections as other health care data covered by HIPAA.
How a scientific slip-up caused a pregnant woman to get an untested treatment for preterm birth
Confusion over Makena, a controversial failed preterm delivery drug, caused some pregnant women to receive an untested treatment.
Cattle testing for H5N1 bird flu will be more limited than USDA initially announced
The USDA order mandating H5N1 bird flu testing in dairy cows is less stringent than initially described by the agency.
Hospitals largely keep quiet on maternal care since Dobbs, STAT survey finds
Of 100 hospitals across 50 states surveyed by STAT about changes in maternal care after overturning of Roe v. Wade, only six agreed to speak.
STAT in DC: Policy in Health Care
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…
Momentum builds for House bill cracking down on Chinese biotechs
House lawmakers are aiming to pass the BIOSECURE ACT in time for it to be included in a year-end must-pass legislative package.
Another hospital sues MultiPlan, alleging scheme to ‘suppress’ payments
MultiPlan faces a class action lawsuit alleging the company and insurers “conspired to fix, suppress, and stabilize” medical payments.